Adaptive Therapy With Capecitabine for Treatment of Metastatic ER Positive, HER2 Negative Breast Cancer

Clinical trial NCT06525766 · RECRUITING

Trial details

NCT number: NCT06525766
Sponsor: Mayo Clinic
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Anatomic Stage IV Breast Cancer AJCC v8 Estrogen-receptor-positive Breast Cancer Metastatic HER2-Negative Breast Carcinoma Metastatic Breast Cancer

Start date: 2025-10-01
Primary completion: 2030-10-15
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.